Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2012
12/20/2012WO2012173452A1 Antimicrobial agent made of ginsenoside compound k or derivatives thereof
12/20/2012WO2012173448A2 Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases
12/20/2012WO2012173447A2 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient
12/20/2012WO2012173392A2 Curcuminoid-based compound/stevioside-containing complex for the prevention and treatment of an influenza virus infection
12/20/2012WO2012173174A1 Azaspiroalkane compound
12/20/2012WO2012173163A1 Crushed cells and composition thereof
12/20/2012WO2012172562A2 Hybrid molecules containing pharmacophores of fluconazole as antifungal agents and their preparation
12/20/2012WO2012172100A1 Use of mecamylamine in the treatment of pathogen-infected patients with central nervous system disorder
12/20/2012WO2012172043A1 Purine derivatives and their use as pharmaceuticals for prevention or treatment of bacterial infections
12/20/2012WO2012172042A1 Vaccines for chlamydia
12/20/2012WO2012172015A1 Process for the preparation of a chiral compound
12/20/2012WO2012171621A1 Pharmaceutical preparation for treating infections of the intestine with ehec bacteria
12/20/2012WO2012171332A1 Macrocyclic heterocyclic compound for inhibiting hepatitis c virus and preparation and use thereof
12/20/2012WO2012171104A1 Rabies virus like particle production in plants
12/20/2012WO2012111920A3 Pharmaceutical composition containing fenofibrate for prevention of sepsis
12/20/2012WO2012080641A8 S1p receptor agonists and use thereof in treating hiv infections
12/20/2012WO2011143772A9 Inhibitors of hiv replication
12/20/2012WO2011110716A3 Peptide compounds that can be used as antibacterial agents
12/20/2012US20120322882 Compositions And Methods For Stimulating Hair Growth
12/20/2012US20120322862 Aptamers to 4-1BB and Their Use in Treating Diseases and Disorders
12/20/2012US20120322847 ANTISENSE ANTIVIRAL COMPOUND AND METHOD FOR TREATING ssRNA VIRAL INFECTION
12/20/2012US20120322815 Pharmaceutical composition containing a3 adenosine receptor agonist
12/20/2012US20120322797 Selective beta-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents
12/20/2012US20120322793 Protein kinase inhibitors
12/20/2012US20120322790 Pyrazolopiperidine Compounds As CCR1 Receptor Antagonists
12/20/2012US20120322783 Tumescent antibiotic solution
12/20/2012US20120322770 Therapeutic compounds for blocking dna synthesis of pox viruses
12/20/2012US20120322769 Methods of reducing virulence in bacteria
12/20/2012US20120322766 Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
12/20/2012US20120322764 Acyclic Nucleoside Phosphonate Derivatives and Medical Uses Thereof
12/20/2012US20120322751 use of rhamnolipids as a drug of choice in the case of nuclear disasters in the treatment of the combination radiation injuries and illnesses in humans and animals
12/20/2012US20120322749 Tableted compositions containing atazanavir
12/20/2012US20120322722 Pyruvamide Compounds as Inhibitors of Dust Mite Group 1 Peptidase Allergen and Their Use
12/20/2012US20120322717 Compounds and assays for controlling Wnt activity
12/20/2012US20120322658 Biocontrol of Storage Maladies of Potatoes by Bacterial Antagonists Produced in Co-Culture
12/20/2012US20120321722 Platelet Storage and Reduced Bacterial Proliferation In Platelet Products Using A Sialidase Inhibitor
12/20/2012US20120321720 Therapeutic application of parenteral krill oil
12/20/2012US20120321710 Controlled Release and Taste Masking Oral Pharmaceutical Composition
12/20/2012US20120321702 Pharmaceutical composition of lansoprazole
12/20/2012US20120321699 Method of inducing the production of protective anti-hiv-1 antibodies
12/20/2012US20120321698 Inhalable pharmaceutical compositions
12/20/2012US20120321695 Use of PVP-Iodine Liposomes for Treatment of Herpes
12/20/2012US20120321692 Methods and Dressings for Sealing Internal Injuries
12/20/2012US20120321691 Clay-based hemostatic agents and devices for the delivery thereof
12/20/2012US20120321687 Compositions and methods for using and identifying antimicrobial agents
12/20/2012US20120321685 Compositions containing oils having a specific gravity higher than the specific gravity of water
12/20/2012US20120321669 Antigenic compositions
12/20/2012US20120321668 PEPTIDES DERIVED FROM HIV-1 gp41 TRANSMEMBRANE
12/20/2012US20120321667 T cell receptor-deficient t cell compositions
12/20/2012US20120321664 Modulation of yeast-based immunotherapy products and responses
12/20/2012US20120321663 Live vaccine for avian diseases
12/20/2012US20120321662 Methods of Eliciting or Boosting a Cellular Immune Response
12/20/2012US20120321661 Recombinant Measles Virus Useful as a Bivalent Vaccine Against Measles and Malarial Infections
12/20/2012US20120321660 Conjugation process of bacterial polysaccharides to carrier proteins
12/20/2012US20120321659 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands
12/20/2012US20120321657 Group a streptococcus multivalent vaccine
12/20/2012US20120321656 Oligopeptides and their use for treating infectious diseases
12/20/2012US20120321655 Lentivirus vaccine based on the recombinant viral vaccine against yellow fever
12/20/2012US20120321653 Novel chimeric polynucleotides and polypeptides enabling the secretion of a polypeptide of interest in combination with exosomes and uses thereof
12/20/2012US20120321647 Structured rna motifs and compounds and methods for their use
12/20/2012US20120321637 Combination cancer therapy with herv inhibition
12/20/2012US20120321616 Stabilized liquid anti-rsv antibody formulations
12/20/2012US20120321603 Composition and method for stabilization and delivery of therapeutic molecules
12/20/2012US20120321600 Infant formula with probiotics and milk fat globule membrane components
12/20/2012US20120321599 Herpes virus strains
12/20/2012US20120321597 Methods and compositions for regenerating connective tissue
12/20/2012US20120321590 Bridged polycyclic compounds
12/20/2012US20120321586 Surfactant composition
12/20/2012US20120321579 Surfactant compositions
12/20/2012US20120321573 Compositions and methods of prophylaxis for contact dermatitis
12/20/2012US20120321571 Paraben compositions
12/20/2012US20120321570 System for caries management by risk assessment
12/20/2012US20120321553 Ultrafiltration Concentration of Allotype Selected Antibodies for Small-Volume Administration
12/20/2012CA2857705A1 Macrocyclic heterocyclic compounds for inhibiting hepatitis c virus and preparation and use thereof
12/20/2012CA2839400A1 Hepatitis c virus inhibitors
12/20/2012CA2839009A1 Rabies virus like particle production in plants
12/20/2012CA2838981A1 Group a streptococcus multivalent vaccine
12/20/2012CA2838703A1 Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases
12/20/2012CA2838680A1 1,3-dioxoindene derivatives, pharmaceutically acceptable salt thereof, preparation method thereof and pharmaceutical composition for the antivirus containing the same as an activeingredient
12/20/2012CA2838051A1 Process for the preparation of a chiral compound
12/20/2012CA2837892A1 Tem8 antibodies, conjugates thereof, and their use
12/20/2012CA2833169A1 Antimicrobial compounds and methods of making and using the same
12/20/2012CA2818907A1 Hybrid molecules containing pharmacophores of fluconazole as antifungal agents and their preparation
12/19/2012EP2535413A2 Splice switching oligomers for the TNF superfamily receptors and their use in treatment of disease
12/19/2012EP2535345A1 Anticancer nucleoside analogs
12/19/2012EP2535056A2 Composition for preventing or treating rotavirus infection containing licorice extract
12/19/2012EP2535046A1 Use of mecamylamine in the treatment of pathogen-infected patients with central nervous system disorder
12/19/2012EP2534155A1 Compounds for treating respiratory syncytial virus infections
12/19/2012EP2534150A2 Methods of treating viral infection
12/19/2012EP2534149A1 6-amino-2-{ [ (1s)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate
12/19/2012EP2534148A1 Purine derivatives and their pharmaceutical uses
12/19/2012EP2533828A1 Removal of virulence factors through extracorporeal therapy
12/19/2012EP2533815A1 Nucleic acid complexes
12/19/2012EP2533802A2 Methods of reducing or inhibiting toxic effects associated with a bacterial infection using alkaline phosphatase
12/19/2012EP2533801A1 Bacterial deoxyribonuclease compounds and methods for biofilm disruption and prevention
12/19/2012EP2533794A1 Protein domains and uses therefor
12/19/2012EP2533793A2 Compositions and uses of lectins
12/19/2012CN102834506A Method for producing regulatory dendritic cells
12/19/2012CN102834409A Cyclosporine analogues
12/19/2012CN102834381A Derivatives of pyridoxine for inhibiting HIV integrase
1 ... 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 ... 1798